世界のリウマチ疾患治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rheumatic Disorders Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5995
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、リウマチ疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍壊死因子-α作用型、インターロイキン・インターロイキン受容体作用型、プロテインキナーゼ作用型、細胞表面抗原作用型、ホルモン・ホルモン受容体作用型、その他）、用途別市場規模（関節リウマチ、変形性関節症、骨粗鬆症、全身性エリテマトーデス、乾癬性関節炎、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・リウマチ疾患治療薬の市場動向
・企業の競争状況、市場シェア
・リウマチ疾患治療薬の種類別市場規模と予測2016-2027（腫瘍壊死因子-α作用型、インターロイキン・インターロイキン受容体作用型、プロテインキナーゼ作用型、細胞表面抗原作用型、ホルモン・ホルモン受容体作用型、その他）
・リウマチ疾患治療薬の用途別市場規模と予測2016-2027（関節リウマチ、変形性関節症、骨粗鬆症、全身性エリテマトーデス、乾癬性関節炎、その他）
・リウマチ疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・リウマチ疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・リウマチ疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・リウマチ疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・リウマチ疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Amgen、Johnson & Johnson、Novartis、Pfizer、Roche、Eli Lilly、Bristol-Myers Squibb）
・結論

Treatment of drugs for regulating rheumatic diseases
Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain control drugs. Treatment is ongoing and there are no treatments for any of the key indications, so there is a need to develop better disease modulating drugs.

Market Analysis and Insights: Global Rheumatic Disorders Drug Market
The global Rheumatic Disorders Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatic Disorders Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatic Disorders Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatic Disorders Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatic Disorders Drug market.

Global Rheumatic Disorders Drug Scope and Market Size
Rheumatic Disorders Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatic Disorders Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acting on Tumor Necrosis Factor-Alpha
Acting on Interleukins and Interleukin Receptors
Acting on Protein Kinases
Acting on Cell Surface Antigens
Acting on Hormones and Hormone Receptors
Others

Segment by Application
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Systemic Lupus Erythematosus
Psoriatic Arthritis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
Johnson & Johnson
Novartis
Pfizer
Roche
Eli Lilly
Bristol-Myers Squibb

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatic Disorders Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acting on Tumor Necrosis Factor-Alpha
1.2.3 Acting on Interleukins and Interleukin Receptors
1.2.4 Acting on Protein Kinases
1.2.5 Acting on Cell Surface Antigens
1.2.6 Acting on Hormones and Hormone Receptors
1.2.7 Others
1.3 Market by Application
1.3.1 Global Rheumatic Disorders Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Osteoporosis
1.3.5 Systemic Lupus Erythematosus
1.3.6 Psoriatic Arthritis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rheumatic Disorders Drug Market Perspective (2016-2027)
2.2 Rheumatic Disorders Drug Growth Trends by Regions
2.2.1 Rheumatic Disorders Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rheumatic Disorders Drug Historic Market Share by Regions (2016-2021)
2.2.3 Rheumatic Disorders Drug Forecasted Market Size by Regions (2022-2027)
2.3 Rheumatic Disorders Drug Industry Dynamic
2.3.1 Rheumatic Disorders Drug Market Trends
2.3.2 Rheumatic Disorders Drug Market Drivers
2.3.3 Rheumatic Disorders Drug Market Challenges
2.3.4 Rheumatic Disorders Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rheumatic Disorders Drug Players by Revenue
3.1.1 Global Top Rheumatic Disorders Drug Players by Revenue (2016-2021)
3.1.2 Global Rheumatic Disorders Drug Revenue Market Share by Players (2016-2021)
3.2 Global Rheumatic Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rheumatic Disorders Drug Revenue
3.4 Global Rheumatic Disorders Drug Market Concentration Ratio
3.4.1 Global Rheumatic Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatic Disorders Drug Revenue in 2020
3.5 Rheumatic Disorders Drug Key Players Head office and Area Served
3.6 Key Players Rheumatic Disorders Drug Product Solution and Service
3.7 Date of Enter into Rheumatic Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatic Disorders Drug Breakdown Data by Type
4.1 Global Rheumatic Disorders Drug Historic Market Size by Type (2016-2021)
4.2 Global Rheumatic Disorders Drug Forecasted Market Size by Type (2022-2027)

5 Rheumatic Disorders Drug Breakdown Data by Application
5.1 Global Rheumatic Disorders Drug Historic Market Size by Application (2016-2021)
5.2 Global Rheumatic Disorders Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rheumatic Disorders Drug Market Size (2016-2027)
6.2 North America Rheumatic Disorders Drug Market Size by Type
6.2.1 North America Rheumatic Disorders Drug Market Size by Type (2016-2021)
6.2.2 North America Rheumatic Disorders Drug Market Size by Type (2022-2027)
6.2.3 North America Rheumatic Disorders Drug Market Size by Type (2016-2027)
6.3 North America Rheumatic Disorders Drug Market Size by Application
6.3.1 North America Rheumatic Disorders Drug Market Size by Application (2016-2021)
6.3.2 North America Rheumatic Disorders Drug Market Size by Application (2022-2027)
6.3.3 North America Rheumatic Disorders Drug Market Size by Application (2016-2027)
6.4 North America Rheumatic Disorders Drug Market Size by Country
6.4.1 North America Rheumatic Disorders Drug Market Size by Country (2016-2021)
6.4.2 North America Rheumatic Disorders Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Rheumatic Disorders Drug Market Size (2016-2027)
7.2 Europe Rheumatic Disorders Drug Market Size by Type
7.2.1 Europe Rheumatic Disorders Drug Market Size by Type (2016-2021)
7.2.2 Europe Rheumatic Disorders Drug Market Size by Type (2022-2027)
7.2.3 Europe Rheumatic Disorders Drug Market Size by Type (2016-2027)
7.3 Europe Rheumatic Disorders Drug Market Size by Application
7.3.1 Europe Rheumatic Disorders Drug Market Size by Application (2016-2021)
7.3.2 Europe Rheumatic Disorders Drug Market Size by Application (2022-2027)
7.3.3 Europe Rheumatic Disorders Drug Market Size by Application (2016-2027)
7.4 Europe Rheumatic Disorders Drug Market Size by Country
7.4.1 Europe Rheumatic Disorders Drug Market Size by Country (2016-2021)
7.4.2 Europe Rheumatic Disorders Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rheumatic Disorders Drug Market Size (2016-2027)
8.2 Asia-Pacific Rheumatic Disorders Drug Market Size by Type
8.2.1 Asia-Pacific Rheumatic Disorders Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rheumatic Disorders Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rheumatic Disorders Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Rheumatic Disorders Drug Market Size by Application
8.3.1 Asia-Pacific Rheumatic Disorders Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rheumatic Disorders Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rheumatic Disorders Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Rheumatic Disorders Drug Market Size by Region
8.4.1 Asia-Pacific Rheumatic Disorders Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rheumatic Disorders Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rheumatic Disorders Drug Market Size (2016-2027)
9.2 Latin America Rheumatic Disorders Drug Market Size by Type
9.2.1 Latin America Rheumatic Disorders Drug Market Size by Type (2016-2021)
9.2.2 Latin America Rheumatic Disorders Drug Market Size by Type (2022-2027)
9.2.3 Latin America Rheumatic Disorders Drug Market Size by Type (2016-2027)
9.3 Latin America Rheumatic Disorders Drug Market Size by Application
9.3.1 Latin America Rheumatic Disorders Drug Market Size by Application (2016-2021)
9.3.2 Latin America Rheumatic Disorders Drug Market Size by Application (2022-2027)
9.3.3 Latin America Rheumatic Disorders Drug Market Size by Application (2016-2027)
9.4 Latin America Rheumatic Disorders Drug Market Size by Country
9.4.1 Latin America Rheumatic Disorders Drug Market Size by Country (2016-2021)
9.4.2 Latin America Rheumatic Disorders Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rheumatic Disorders Drug Market Size (2016-2027)
10.2 Middle East & Africa Rheumatic Disorders Drug Market Size by Type
10.2.1 Middle East & Africa Rheumatic Disorders Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rheumatic Disorders Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rheumatic Disorders Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Rheumatic Disorders Drug Market Size by Application
10.3.1 Middle East & Africa Rheumatic Disorders Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rheumatic Disorders Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rheumatic Disorders Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Rheumatic Disorders Drug Market Size by Country
10.4.1 Middle East & Africa Rheumatic Disorders Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rheumatic Disorders Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Rheumatic Disorders Drug Introduction
11.1.4 AbbVie Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Rheumatic Disorders Drug Introduction
11.2.4 Amgen Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Rheumatic Disorders Drug Introduction
11.3.4 Johnson & Johnson Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Rheumatic Disorders Drug Introduction
11.4.4 Novartis Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Rheumatic Disorders Drug Introduction
11.5.4 Pfizer Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Rheumatic Disorders Drug Introduction
11.6.4 Roche Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Rheumatic Disorders Drug Introduction
11.7.4 Eli Lilly Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.7.5 Eli Lilly Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Rheumatic Disorders Drug Introduction
11.8.4 Bristol-Myers Squibb Revenue in Rheumatic Disorders Drug Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rheumatic Disorders Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acting on Tumor Necrosis Factor-Alpha
Table 3. Key Players of Acting on Interleukins and Interleukin Receptors
Table 4. Key Players of Acting on Protein Kinases
Table 5. Key Players of Acting on Cell Surface Antigens
Table 6. Key Players of Acting on Hormones and Hormone Receptors
Table 7. Key Players of Others
Table 8. Global Rheumatic Disorders Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Rheumatic Disorders Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Rheumatic Disorders Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Rheumatic Disorders Drug Market Share by Regions (2016-2021)
Table 12. Global Rheumatic Disorders Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Rheumatic Disorders Drug Market Share by Regions (2022-2027)
Table 14. Rheumatic Disorders Drug Market Trends
Table 15. Rheumatic Disorders Drug Market Drivers
Table 16. Rheumatic Disorders Drug Market Challenges
Table 17. Rheumatic Disorders Drug Market Restraints
Table 18. Global Rheumatic Disorders Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Rheumatic Disorders Drug Market Share by Players (2016-2021)
Table 20. Global Top Rheumatic Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Disorders Drug as of 2020)
Table 21. Ranking of Global Top Rheumatic Disorders Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Rheumatic Disorders Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rheumatic Disorders Drug Product Solution and Service
Table 25. Date of Enter into Rheumatic Disorders Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rheumatic Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Rheumatic Disorders Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Rheumatic Disorders Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Rheumatic Disorders Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Rheumatic Disorders Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Rheumatic Disorders Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Rheumatic Disorders Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Rheumatic Disorders Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Rheumatic Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Rheumatic Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Rheumatic Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Rheumatic Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Rheumatic Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Rheumatic Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Rheumatic Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Rheumatic Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Rheumatic Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Rheumatic Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Rheumatic Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Rheumatic Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rheumatic Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Rheumatic Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Rheumatic Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Rheumatic Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Rheumatic Disorders Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Rheumatic Disorders Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Rheumatic Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Rheumatic Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Rheumatic Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Rheumatic Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Rheumatic Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Rheumatic Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rheumatic Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Rheumatic Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Rheumatic Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Rheumatic Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Rheumatic Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Rheumatic Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. AbbVie Company Details
Table 66. AbbVie Business Overview
Table 67. AbbVie Rheumatic Disorders Drug Product
Table 68. AbbVie Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 69. AbbVie Recent Development
Table 70. Amgen Company Details
Table 71. Amgen Business Overview
Table 72. Amgen Rheumatic Disorders Drug Product
Table 73. Amgen Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 74. Amgen Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Rheumatic Disorders Drug Product
Table 78. Johnson & Johnson Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Rheumatic Disorders Drug Product
Table 83. Novartis Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Rheumatic Disorders Drug Product
Table 88. Pfizer Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 89. Pfizer Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Rheumatic Disorders Drug Product
Table 93. Roche Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 94. Roche Recent Development
Table 95. Eli Lilly Company Details
Table 96. Eli Lilly Business Overview
Table 97. Eli Lilly Rheumatic Disorders Drug Product
Table 98. Eli Lilly Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly Recent Development
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Revenue in Rheumatic Disorders Drug Business (2016-2021) & (US$ Million)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatic Disorders Drug Market Share by Type: 2020 VS 2027
Figure 2. Acting on Tumor Necrosis Factor-Alpha Features
Figure 3. Acting on Interleukins and Interleukin Receptors Features
Figure 4. Acting on Protein Kinases Features
Figure 5. Acting on Cell Surface Antigens Features
Figure 6. Acting on Hormones and Hormone Receptors Features
Figure 7. Others Features
Figure 8. Global Rheumatic Disorders Drug Market Share by Application: 2020 VS 2027
Figure 9. Rheumatoid Arthritis Case Studies
Figure 10. Osteoarthritis Case Studies
Figure 11. Osteoporosis Case Studies
Figure 12. Systemic Lupus Erythematosus Case Studies
Figure 13. Psoriatic Arthritis Case Studies
Figure 14. Others Case Studies
Figure 15. Rheumatic Disorders Drug Report Years Considered
Figure 16. Global Rheumatic Disorders Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Rheumatic Disorders Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Rheumatic Disorders Drug Market Share by Regions: 2020 VS 2027
Figure 19. Global Rheumatic Disorders Drug Market Share by Regions (2022-2027)
Figure 20. Global Rheumatic Disorders Drug Market Share by Players in 2020
Figure 21. Global Top Rheumatic Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Disorders Drug as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Rheumatic Disorders Drug Revenue in 2020
Figure 23. Global Rheumatic Disorders Drug Revenue Market Share by Type (2016-2021)
Figure 24. Global Rheumatic Disorders Drug Revenue Market Share by Type (2022-2027)
Figure 25. North America Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Rheumatic Disorders Drug Market Share by Type (2016-2027)
Figure 27. North America Rheumatic Disorders Drug Market Share by Application (2016-2027)
Figure 28. North America Rheumatic Disorders Drug Market Share by Country (2016-2027)
Figure 29. United States Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Rheumatic Disorders Drug Market Share by Type (2016-2027)
Figure 33. Europe Rheumatic Disorders Drug Market Share by Application (2016-2027)
Figure 34. Europe Rheumatic Disorders Drug Market Share by Country (2016-2027)
Figure 35. Germany Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Rheumatic Disorders Drug Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Rheumatic Disorders Drug Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Rheumatic Disorders Drug Market Share by Region (2016-2027)
Figure 45. China Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Rheumatic Disorders Drug Market Share by Type (2016-2027)
Figure 53. Latin America Rheumatic Disorders Drug Market Share by Application (2016-2027)
Figure 54. Latin America Rheumatic Disorders Drug Market Share by Country (2016-2027)
Figure 55. Mexico Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Rheumatic Disorders Drug Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Rheumatic Disorders Drug Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Rheumatic Disorders Drug Market Share by Country (2016-2027)
Figure 61. Turkey Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Rheumatic Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. AbbVie Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Rheumatic Disorders Drug Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の不安障害＆うつ病治療薬市場規模・現状・予測（2021年-2027年）

Global Anxiety Disorders And Depression Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5593 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、不安障害＆うつ病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、SNRI、TeCA、TCA、MAOI、非定型抗精神病薬、ベンゾジアゼピン、抗けいれん薬、ベータ遮断薬、その他）、用途別市...

世界の血圧障害薬市場規模・現状・予測（2021年-2027年）

Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2021-2027
QFJ1-3919 2021年6月 125Pages
QYResearch社発行の本調査レポートでは、血圧障害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、その他）、用途別市場規模（高血圧症、低血圧症、肺高血...

世界の神経疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4568 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経系（CNS）、末梢神経系（PNS））、用途別市場規模（麻痺、筋力低下、協調運動不全、感覚喪失、発作、錯乱、疼痛、意識レベル変化）、...

世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年）

Global Frontotemporal Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4238 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、前頭側頭型認知症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（向知性薬、抗精神病薬、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年）

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の眼科疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Ophthalmology Disorders Drug Market Size, Status and Forecast 2021-2027
QFJ1-4615 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、眼科疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬、外用薬）、用途別市場規模（若年性黄斑変性症（シュタルガルト病）、レーバー先天性黒内障（LCA）、レーバー遺伝性視神経症（L...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-4248 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（...

世界のミトコンドリア病治療市場規模・現状・予測（2021年-2027年）

Global Mitochondrial Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5865 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ミトコンドリア病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダイエット療法、ビタミン・サプリメント療法、パイプライン療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の糖原病（GSD）臨床試験市場規模・現状・予測（2021年-2027年）

Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, Status and Forecast 2021-2027
QFJ1-4266 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、糖原病（GSD）臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の速効型インスリン市場規模・現状・予測（2021年-2027年） Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump. Market Analysis and Insights: Global Rapid …
世界の長時間作用型インスリン市場規模・現状・予測（2021年-2027年） Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of d…
世界の急速充電市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Quick-acting Charging Market The global Quick-acting Charging market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
世界の長時間作用型注射薬市場規模・現状・予測（2021年-2027年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…
世界の直接作用型抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Direct-acting Antiviral Drugs Market The global Direct-acting Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…